ISB News

Dr. Jennifer Hadlock Promoted to Associate Professor

Dr. Hadlock

Jennifer Hadlock, MD – an expert in machine learning, immune-mediated inflammatory disease, and maternal/fetal health – has been promoted to associate professor. 

“Jenn is a superb scientist. Since she joined ISB in 2018, she has published many important papers, collaborated with clinicians, established  her lab, and led many federal- and industry-supported projects. We are fortunate to have her on our faculty,” said ISB President Dr. Jim Heath

The Hadlock Lab is an interdisciplinary team that aims to accelerate translational research by integrating clinical data into systems biology at scale. 

Hadlock’s goal is to improve the lives of people with immune-mediated inflammatory diseases (IMIDs) such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, and others. IMIDs affect over 8 percent of the population, and the diseases are frequently underdiagnosed. Individuals can experience years of delay before diagnosis, and may undergo multiple treatments before finding which ones are beneficial.

“I believe the work my lab is doing around IMIDs will benefit people who have these conditions, while also advancing our fundamental understanding of biology. I am tremendously excited about the strides we’ve made and what is to come, and I am truly honored with this promotion,” Hadlock said.

Hadlock and colleagues have published several papers, including research showing how maternal COVID-19 infection increases risks of preterm birth and other poor birth outcomes, knowledge graphs for biomedical translation and how risk factors for severe COVID-19 in hospitalized adults differ by age. Her research has been covered by a variety of news outlets, including Forbes, CBS News and MSN. 

Prior to joining ISB, Hadlock earned her medical degree from the University of Washington. Prior to attending med school, she was a principal software manager at Microsoft, where she led numerous teams working on systems to validate and verify technologies used by hundreds of millions of people across the globe.

Recent Articles

  • 2024 Year in Review

    Reflecting on the past year, ISB has a lot to celebrate: groundbreaking research published in leading scientific journals, well-earned promotions, widespread media coverage, and more. Enjoy our year-in-review roundup highlighting some of the important, interesting, and impactful highlights of 2024.

  • My Digital Gut

    ISB Named Winner of 2024-2025 Amazon Web Services IMAGINE Grant for Nonprofits

    ISB has been selected as a winner of the 2024 Amazon Web Services (AWS) IMAGINE Grant. The grant will support ISB’s continued development of My Digital Gut, an online decision-support platform that will help make microbiome-informed nutrition and healthcare personalized, predictive, and preventive. 

  • ISB-Developed MetaboCore Offers Precision Cancer Care Faster Than Ever 

    ISB Associate Professor Dr. Wei Wei and his colleagues have developed a promising new companion diagnostic tool called MetaboCore to help physicians quickly select the most effective systemic therapy for each cancer patient.